erythrodiol has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, R; Singh, S; Singh, SK | 1 |
1 other study(ies) available for erythrodiol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia.
Topics: Binding Sites; COVID-19; COVID-19 Drug Treatment; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Momordica charantia; Oleanolic Acid; Plant Extracts; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Surface Plasmon Resonance | 2021 |